Genome wiz Venter partners with Roche in DNA sequencing deal

CHICAGO (Reuters) – Genome pioneer J. Craig Venter has signed a multi-year deal to sequence and analyze tens of thousands of genomes for Roche’s Genentech unit in a deal aimed at identifying new drug targets and biomarkers, the companies said on Wednesday.

—> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *